Creutzfeldt–Jakob disease and other prion diseases

Alemà, G. in Proceedings of the 5th World Congress of Psychiatry (eds de la Fuente, R. & Weisman, M. N.) 1221–1227 (American Elsevier, 1973).

Masters, C. L. et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann. Neurol. 5, 177–188 (1979).

Article  CAS  PubMed  Google Scholar 

Will, R. G. et al. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD. Ann. Neurol. 43, 763–767 (1998).

Article  CAS  PubMed  Google Scholar 

Watson, N. et al. The importance of ongoing international surveillance for Creutzfeldt-Jakob disease. Nat. Rev. Neurol. 17, 362–379 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Watson, N. et al. Validation of revised International Creutzfeldt-Jakob disease surveillance network diagnostic criteria for sporadic Creutzfeldt-Jakob disease. JAMA Netw. Open. 5, e2146319 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Ladogana, A. et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 64, 1586–1591 (2005). This study provides comparative data on disease mortality in Europe as a joint effort of national surveillance systems.

Article  CAS  PubMed  Google Scholar 

Ladogana, A. et al. Creutzfeldt-Jakob disease: the public health perception. Eur. J. Neurodeg Dis. 1, 101–113 (2012).

Google Scholar 

D’Aignaux, J. H. et al. Analysis of the geographical distribution of sporadic Creutzfeldt-Jakob disease in France between 1992 and 1998. Int. J. Epidemiol. 31, 490–495 (2002).

Article  PubMed  Google Scholar 

Nakatani, E. et al. Temporal and regional variations in sporadic Creutzfeldt-Jakob disease in Japan, 2001-2010. Epidemiol. Infect. 143, 1073–1078 (2015).

Article  CAS  PubMed  Google Scholar 

Puopolo, M. et al. Spatial epidemiology of sporadic Creutzfeldt-Jakob disease in Apulia, Italy. Neuroepidemiology 54, 83–90 (2020).

Article  PubMed  Google Scholar 

Klug, G. M. et al. Intensity of human prion disease surveillance predicts observed disease incidence. J. Neurol. Neurosurg. Psychiatry 84, 1372–1377 (2013).

Article  PubMed  Google Scholar 

Sun, Y. et al. Incidence of and mortality due to human prion diseases in Taiwan: a prospective 20-year nationwide surveillance study from 1998 to 2017. Clin. Epidemiol. 12, 1073–1081 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Stehmann, C. et al. Communicable Diseases Intelligence. Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2022. Commonwealth of Australia Department of Health and Aged Care https://doi.org/10.33321/cdi.2023.47.37 (2023).

Kim, Y. C. & Jeong, B. H. Creutzfeldt-Jakob disease incidence, South Korea, 2001-2019. Emerg. Infect. Dis. 28, 1863–1866 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Government of Canada. Creutzfeldt-Jakob Disease Surveillance System (CJDSS) report. Government of Canada www.canada.ca/en/public-health/services/surveillance/blood-safety-contribution-program/creutzfeldt-jakob-disease/cjd-surveillance-system.html (2023).

Hermann, P. et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 20, 235–246 (2021). This paper summarizes the current knowledge on clinical biomarkers and consensus guidelines by experts from national CJD surveillance systems for clinical diagnosis.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parchi, P. et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46, 224–233 (1999).

Article  CAS  PubMed  Google Scholar 

Denouel, A. et al. The role of environmental factors on sporadic Creutzfeldt-Jakob disease mortality: evidence from an age-period-cohort analysis. Eur. J. Epidemiol. 38, 757–764 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Pocchiari, M. et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 127, 2348–2359 (2004).

Article  CAS  PubMed  Google Scholar 

Alperovitch, A. et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 353, 1673–1674 (1999). This paper provides evidence for the role of the codon 129 genotype of the prion protein gene in disease susceptibility in sporadic CJD.

Article  CAS  PubMed  Google Scholar 

Palmer, M. S., Dryden, A. J., Hughes, J. T. & Collinge, J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352, 340–342 (1991).

Article  ADS  CAS  PubMed  Google Scholar 

Prusiner, S. B. Prions. Proc. Natl Acad. Sci. USA 95, 13363–13383 (1998).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Mead, S., Lloyd, S. & Collinge, J. Genetic factors in mammalian prion diseases. Annu. Rev. Genet. 53, 117–147 (2019).

Article  CAS  PubMed  Google Scholar 

Brown, P. et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol. 35, 513–529 (1994).

Article  CAS  PubMed  Google Scholar 

Tateishi, J. et al. First experimental transmission of fatal familial insomnia. Nature 376, 434–435 (1995).

Article  ADS  CAS  PubMed  Google Scholar 

Tateishi, J., Kitamoto, T., Hoque, M. Z. & Furukawa, H. Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Neurology 46, 532–537 (1996).

Article  CAS  PubMed  Google Scholar 

Minikel, E. V. et al. Quantifying prion disease penetrance using large population control cohorts. Sci. Transl. Med. 8, 322ra329 (2016).

Article  Google Scholar 

Kovacs, G. G. et al. Genetic prion disease: the EUROCJD experience. Hum. Genet. 118, 166–174 (2005).

Article  CAS  PubMed  Google Scholar 

Kim, D. Y., Shim, K. H., Bagyinszky, E. & An, S. S. A. Prion mutations in Republic of Republic of Korea, China, and Japan. Int. J. Mol. Sci. 24, 625 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Ladogana, A. & Kovacs, G. G. Genetic Creutzfeldt-Jakob disease. Handb. Clin. Neurol. 153, 219–242 (2018).

Article  PubMed  Google Scholar 

Brown, P. et al. Familial Creutzfeldt-Jakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20. J. Neurol. Sci. 112, 65–67 (1992).

Article  CAS  PubMed  Google Scholar 

Duffy, P. et al. Letter: possible person-to-person transmission of Creutzfeldt-Jakob disease. N. Engl. J. Med. 290, 692–693 (1974).

Article  CAS  PubMed  Google Scholar 

Brown, P. et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg. Infect. Dis. 18, 901–907 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Rudge, P. et al. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Brain 138, 3386–3399 (2015).

Article  PubMed  PubMed Central  Google Scholar 

National CJD. Surveillance Unit. Creutzfeldt-Jakob disease in the UK. NCJDRSU www.cjd.ed.ac.uk/sites/default/files/figs.pdf (2024).

Takumi, I. & Akino, K. Creutzfeldt-Jakob disease and lyodura:a special reference to prion disease control in the field of neurosurgery [Japanese]. No Shinkei Geka 50, 1078–1086 (2022).

PubMed  Google Scholar 

Hamaguchi, T. et al. Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan. J. Neurol. Neurosurg. Psychiatry 84, 1171–1175 (2013).

Article  PubMed  Google Scholar 

Kobayashi, Y., Kitamoto, T. & Mizusawa, H. Iatrogenic Creutzfeldt-Jakob disease. Handb. Clin. Neurol. 153, 207–218 (2018).

Article  PubMed  Google Scholar 

Brandel, J. P. et al. Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 362, 128–130 (2003).

Article  CAS  PubMed  Google Scholar 

Peckeu, L. et al. Factors influencing the incubation of an infectious form of Creutzfeldt-Jakob disease. Clin. Infect. Dis. 70, 1487–1490 (2020).

CAS  PubMed  Google Scholar 

Will, R. G. et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921–925 (1996).

Article  CAS  PubMed  Google Scholar 

Diack, A. B. et al. Variant CJD. 18 years of research and surveillance. Prion 8, 286–295 (2014).

Article  CAS  PubMed 

留言 (0)

沒有登入
gif